Sotera Health (SHC) Price to Sales (2020 - 2026)

Sotera Health has reported Price to Sales for 7 years, with the latest figure at 15.76 in Q2 2026.

• On a quarterly basis, Price to Sales rose 46.88% year-over-year to 15.76 in Q2 2026; TTM through Jun 2026 was 4.17, a 48.28% increase from a year earlier, with the FY2025 full-year figure at 4.31, up 22.34% from the prior year.
• Price to Sales was 15.76 for Q2 2026 at Sotera Health, up from 14.6 in the prior quarter.
• The five-year high for Price to Sales was 25.87 in Q1 2022, with the low at 7.74 in Q3 2022.
• Average Price to Sales over 5 years is 15.54, with a median of 14.98 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Price to Sales slumped 76.35% in 2022, then soared 107.94% in 2023.
• Over 5 years, Price to Sales stood at 9.35 in 2022, then jumped by 64.28% to 15.36 in 2023, then declined by 13.01% to 13.36 in 2024, then advanced by 23.72% to 16.53 in 2025, then fell by 4.66% to 15.76 in 2026.
• The last three Price to Sales figures came in at 15.76 (Q2 2026), 14.6 (Q1 2026), and 16.53 (Q4 2025), per Business Quant data.